Furazolidone

Furazolidone

Clinical data
Routes of administration	Oral-Local
Identifiers
IUPAC name 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one
CAS Number	67-45-8
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

WikiDoc Resources for Furazolidone
Articles
Most recent articles on Furazolidone Most cited articles on Furazolidone Review articles on Furazolidone Articles on Furazolidone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Furazolidone Images of Furazolidone Photos of Furazolidone Podcasts & MP3s on Furazolidone Videos on Furazolidone
Evidence Based Medicine
Cochrane Collaboration on Furazolidone Bandolier on Furazolidone TRIP on Furazolidone
Clinical Trials
Ongoing Trials on Furazolidone at Clinical Trials.gov Trial results on Furazolidone Clinical Trials on Furazolidone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Furazolidone NICE Guidance on Furazolidone NHS PRODIGY Guidance FDA on Furazolidone CDC on Furazolidone
Books
Books on Furazolidone
News
Furazolidone in the news Be alerted to news on Furazolidone News trends on Furazolidone
Commentary
Blogs on Furazolidone
Definitions
Definitions of Furazolidone
Patient Resources / Community
Patient resources on Furazolidone Discussion groups on Furazolidone Patient Handouts on Furazolidone Directions to Hospitals Treating Furazolidone Risk calculators and risk factors for Furazolidone
Healthcare Provider Resources
Symptoms of Furazolidone Causes & Risk Factors for Furazolidone Diagnostic studies for Furazolidone Treatment of Furazolidone
Continuing Medical Education (CME)
CME Programs on Furazolidone
International
Furazolidone en Espanol Furazolidone en Francais
Business
Furazolidone in the Marketplace Patents on Furazolidone
Experimental / Informatics
List of terms related to Furazolidone

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Furazolidone is an antibiotic used to treat diarrhea and enteritis caused by bacteria or protozoan infections. It is marketed by Roberts Laboratories under the brand name Furoxone and by GlaxoSmithKline as Dependal-M.

Furazolidone is also used in combination with fluids for treatment of acute infantile diarrhea. Furazolidone is also used to treat traveler's diarrhea, cholera, and bacteremic salmonellosis.

As a veterinary medicine, furazolidone has been used with some success to treat salmonids for Myxobolus cerebralis infections. This drug is commonly prescribed to infants and children in oral suspension. The drug is the most common treatment of diarrhea caused by water borne diseases.